Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in LENZ — LENZ Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to LENZ Full portfolio

Position in LENZ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,450,728
-$3,559,207 QoQ
Shares Held
255,410
-53.4% QoQ
Ownership
0.813%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LENZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. LENZ ranks #199 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in LENZ

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,450,728 255,410
2026-03-31 $5,009,935 547,534
2025-12-31 $1,835,008 114,688
2025-09-30 $16,262,380 349,128
2025-06-30 $1,992,433 67,978
2025-03-31 $471,134 18,325
2024-12-31 $1,104,160 38,246
2024-09-30 $471,262 19,851
2024-06-30 $288,880 16,708
2024-03-31 $87,689 3,927